![Dan Hicklin](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Dan Hicklin
Founder at
WEREWOLF THERAPEUTICS, INC.
Net worth: 291 171 $ as of 2026-05-30
Profile
Daniel J.
Hicklin is the founder of Potenza Therapeutics, Inc., founded in 2014, where the title held was President, Chief Executive Officer & Director from 2014 to 2018.
Dr. Hicklin is the founder of Werewolf Therapeutics, Inc., founded in 2017, holding the titles of President, Chief Executive Officer & Director since 2019.
Dr. Hicklin currently holds the position of Director at Maverick Therapeutics, Inc. Former positions include President & Chief Executive Officer at Trieza Therapeutics, Inc., Managing Director at MPM BioImpact LLC, Director at Tizona Therapeutics, Inc., Vice President at ImClone LLC from 1987 to 2006, Assistant Professor at New York Medical College, Principal at Merck Research Laboratories Massachusetts LLC in 2013, and President & Chief Scientific Officer at CoStim Pharmaceuticals, Inc. from 2013 to 2014.
Education includes undergraduate studies at the University of Iowa and graduate and doctorate degrees from New York Medical College.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2025-04-13 | 647,047 ( 1.33% ) | 291 171 $ | 2026-05-30 |
Dan Hicklin active positions
| Companies | Position | Start |
|---|---|---|
| WEREWOLF THERAPEUTICS, INC. | Founder | 2017-10-18 |
Maverick Therapeutics, Inc.
 Maverick Therapeutics, Inc. BiotechnologyHealth Technology Operates as a preclinical stage biotech company which develops T cell redirecting antibody therapeutics | Director/Board Member | - |
Former positions of Dan Hicklin
| Companies | Position | End |
|---|---|---|
Potenza Therapeutics, Inc.
 Potenza Therapeutics, Inc. BiotechnologyHealth Technology Develops oncology programs and mechanisms for tumors detection | Founder | 2018-11-30 |
CoStim Pharmaceuticals, Inc.
 CoStim Pharmaceuticals, Inc. BiotechnologyHealth Technology Operates as a biotech company which develops biologics for oncology indications | President | 2014-01-31 |
Merck Research Laboratories Massachusetts LLC
 Merck Research Laboratories Massachusetts LLC Pharmaceuticals: MajorHealth Technology Discovers, develops, and markets a broad range of human and animal health products | Corporate Officer/Principal | 2013-12-30 |
ImClone LLC
 ImClone LLC BiotechnologyHealth Technology Develops novel therapeutic products and blood cell growth factors for the treatment of cancer | Corporate Officer/Principal | - |
Trieza Therapeutics, Inc.
 Trieza Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Provides pharmaceutical services | Chief Executive Officer | - |
Training of Dan Hicklin
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
75
1st degree connections
11
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 11 |
|---|---|
ImClone LLC
ImClone LLC BiotechnologyHealth Technology Develops novel therapeutic products and blood cell growth factors for the treatment of cancer | Health Technology |
Potenza Therapeutics, Inc.
Potenza Therapeutics, Inc. BiotechnologyHealth Technology Develops oncology programs and mechanisms for tumors detection | Health Technology |
MPM BioImpact LLC
 MPM BioImpact LLC Investment ManagersFinance MPM Capital invests in both public and private companies located in the United States. The firm targets companies operating in the fields of biotechnology, healthcare and life science sectors. It participates in early stage capital transactions. | Finance |
University of Iowa
 University of Iowa Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
New York Medical College
 New York Medical College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Merck Research Laboratories Massachusetts LLC
Merck Research Laboratories Massachusetts LLC Pharmaceuticals: MajorHealth Technology Discovers, develops, and markets a broad range of human and animal health products | Health Technology |
CoStim Pharmaceuticals, Inc.
CoStim Pharmaceuticals, Inc. BiotechnologyHealth Technology Operates as a biotech company which develops biologics for oncology indications | Health Technology |
Tizona Therapeutics, Inc.
 Tizona Therapeutics, Inc. BiotechnologyHealth Technology Develops and manufactures immuno therapies | Health Technology |
Trieza Therapeutics, Inc.
Trieza Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Provides pharmaceutical services | Health Technology |
Maverick Therapeutics, Inc.
Maverick Therapeutics, Inc. BiotechnologyHealth Technology Operates as a preclinical stage biotech company which develops T cell redirecting antibody therapeutics | Health Technology |
Werewolf Therapeutics, Inc.
 Werewolf Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures medicines for cancer | Health Technology |
- Stock Market
- Insiders
- Dan Hicklin
